Evans David C 4

What Happened

• David C. Evans, a director of Scotts Miracle‑Gro Co. (SMG), was granted a derivative award on March 6, 2026 representing 105 shares. The transaction is coded as an award/acquisition (A); no purchase price is reported (N/A) because this is a grant rather than an open‑market trade.
• This award consists of dividend equivalent rights tied to DSU/RSU grants (see footnote). These rights are the economic equivalent of common shares and become exercisable proportionately with the underlying DSUs/RSUs. No dollar value or immediate cash consideration is provided in the filing.

Key Details

• Transaction date: 2026-03-06; Form 4 filed: 2026-03-09 (appears to be within the normal reporting window).
• Transaction type: Award/Grant (derivative); amount: 105 shares; price: N/A.
• Shares owned after transaction: not specified in the information provided.
• Footnote: Dividend equivalent rights accrued on DSU/RSU grants and become exercisable proportionately with those awards; each dividend equivalent right equals the economic equivalent of one common share.
• No indication of a 10b5-1 plan, cashless exercise, gift, or tax‑withholding action noted in the provided data.

Context

• This is a compensation-related grant, not an open‑market purchase or sale, so it reflects routine director compensation rather than a direct buy/sell signal. Dividend equivalent rights tied to DSUs/RSUs typically convert or settle later under the award plan terms.